<DOC>
	<DOCNO>NCT02078479</DOCNO>
	<brief_summary>The purpose study isto assess efficacy daily 10 session rTMS primary motor cortex patient suffer malignant neuropathic pain . Thirty four patient divide randomly 2 group equally use closed envelops undergo real ( 20 Hz , 10 second , 10 train inter-train interval 30 second total pulse 2000 , intensity 80 % motor threshold hand area motor cortex ) sham rTMS ( parameter coil elevate angle away head ) every day ten consecutive day ( 5 days/week ) . Patients evaluate use verbal descriptor scale ( VDS ) , visual analog scale ( VAS ) , Leeds assessment neuropathic symptom sign ( LANSS ) Hamilton rating scale depression ( HAM-D ) baseline , 1st , 5th , 10thtreatment session , 15 day 1 month end treatment . ic pain .</brief_summary>
	<brief_title>rTMS Treatment Neuropathic Pain Secondary Malignancy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>All patient within age group 1865 year malignant lateralize neuropathic pain resistant medical treatment least 2 month associate significant adverse effect medication involve study . Patients intracranial metallic device Patients pacemaker device . Patients recent myocardial ischemia , unstable angina Patients know history epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Malignancy</keyword>
	<keyword>VAS</keyword>
	<keyword>LANSS</keyword>
	<keyword>VDS</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>rTMS</keyword>
	<keyword>motor cortex</keyword>
	<keyword>analgesia</keyword>
</DOC>